Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Drug Class

  2.3.2 Market Size By Disease Type

  2.3.3 Market Size By Route of Administration

 2.3.4 Market Size By End User

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Drug Discovery & Active Pharmaceutical Ingredient (API) Suppliers

  3.4.2 Therapeutics Manufacturers & Biopharmaceutical Companies

  3.4.3 Distribution Partners, Specialty Pharmacies & Healthcare Providers

  3.4.4 Hospitals, Neurology Clinics & Patients

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

 4.1 Epidemiology & Disease Burden Analysis

  4.1.1 Overview

  4.1.2 ALS Prevalence & Incidence Analysis, By Key Countries, 2022–2035

  4.1.3 Disease Burden & Patient Population Trends, By Disease Type

 4.2 Treatment Landscape Analysis

  4.2.1 Overview

  4.2.2 Current Standard of Care & Treatment Adoption Trends

  4.2.3 Treatment Pathway Analysis, By Disease Stage & Drug Class

 4.3 Innovation & Clinical Development Analysis

  4.3.1 Overview

  4.3.2 Clinical Trial Pipeline Analysis, By Drug Class

  4.3.3 Emerging Therapeutic Technologies

  4.3.4 Patent & Innovation Landscape Analysis

  4.3.5 Future Therapeutic Development Outlook

5. Amyotrophic Lateral Sclerosis Therapeutics Market Segmental Analysis & Forecast, By Drug Class, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Disease-Modifying Therapies

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

 5.3 Neuroprotective Drugs

 5.4 Gene & RNA Therapies

 5.5 Symptomatic Therapies

 5.6 Others

6. Amyotrophic Lateral Sclerosis Therapeutics Market Segmental Analysis & Forecast, By Disease Type, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Sporadic ALS

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Familial ALS

7. Amyotrophic Lateral Sclerosis Therapeutics Market Segmental Analysis & Forecast, By Route of Administration, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Oral

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Intravenous Infusion

 7.4 Intrathecal Administration

 7.5 Subcutaneous Injection

 7.6 Others

8. Amyotrophic Lateral Sclerosis Therapeutics Market Segmental Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Hospitals

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Neurology Specialty Clinics

 8.4 Retail & Specialty Pharmacies

 8.5 Academic & Research Institutes

 8.6 Others

9. Amyotrophic Lateral Sclerosis Therapeutics Market Segmental Analysis & Forecast By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Drug Class, 2022–2035

 9.2.3 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Disease Type, 2022–2035

 9.2.4 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Route of Administration, 2022–2035

 9.2.5 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By End User, 2022–2035

 9.2.6 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Drug Class, 2022–2035

 9.3.3 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Disease Type, 2022–2035

 9.3.4 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Route of Administration, 2022–2035

 9.3.5 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By End User, 2022–2035

 9.3.6 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Drug Class, 2022–2035

 9.4.3 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Disease Type, 2022–2035

 9.4.4 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Route of Administration, 2022–2035

 9.4.5 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By End User, 2022–2035

 9.4.6 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Drug Class, 2022–2035

 9.5.3 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Disease Type, 2022–2035

 9.5.4 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Route of Administration, 2022–2035

 9.5.5 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By End User, 2022–2035

 9.5.6 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Drug Class, 2022–2035

 9.6.3 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Disease Type, 2022–2035

 9.6.4 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Route of Administration, 2022–2035

 9.6.5 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By End User, 2022–2035

 9.6.6 Amyotrophic Lateral Sclerosis Therapeutics Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 South Africa

  9.6.6.5 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Drug Class/Service & Disease Type Benchmarking

  10.4.1 Drug Class/Service Specifications & Features By Key Players

  10.4.2 Drug Class/Service Heatmap By Key Players

  10.4.3 Disease Type Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

  10.6.1 Biogen Inc.

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Drug Class/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

  10.6.2 Ionis Pharmaceuticals, Inc.

10.6.3 Mitsubishi Tanabe Pharma Corporation

10.6.4 Amylyx Pharmaceuticals, Inc.

10.6.5 Sanofi

10.6.6 Denali Therapeutics Inc.

10.6.7 F. Hoffmann-La Roche Ltd.

10.6.8 Cytokinetics, Inc.

10.6.9 Apellis Pharmaceuticals, Inc.

10.6.10 BrainStorm Cell Therapeutics Inc.

10.6.11 AbbVie Inc.

10.6.12 ITF Pharma, Inc.

10.6.13 Eli Lilly and Company

10.6.14 Merck & Co., Inc.

10.6.15 Novartis AG

10.6.16 QurAlis Corporation

10.6.17 Clene Nanomedicine, Inc.

10.6.18 MediciNova, Inc.

10.6.19 GSK plc

10.6.20 NeuroSense Therapeutics Ltd.

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures